Q4 2024Management ViewCEO Dame Emma Walmsley highlighted that GSK achieved 8% sales growth in 2024, reaching over ...

A summary of the latest financial news from European markets, including stock performance, unemployment rates, trade surplus, bond yields, and ...

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.

GSK reports better-than-expected Q4 earnings. It also announces a new share buyback program and raises the long-term sales outlook for 2031 by $2 billion.

GSK forecast sales in 2025 to grow 3%-5% and reported better-than-expected fourth-quarter earnings, as strength in its HIV ...

Shares in Google-parent Alphabet (GOOGL, GOOG) tumbled in after-hours trading following the release of the tech giant's ...

The pharmaceutical giant targets an increase in core operating profit of between 6% and 8% in 2025, after cancer treatments ...

European markets opened mixed on Wednesday, with investors looking ahead to more earnings from a number of key companies.

MORE than a trillion dollars were wiped off some of the world’s biggest tech firms yesterday after markets were blindsided by ...

Markets were on edge on Monday, with the FTSE 100 ( ^FTSE) almost flat and European and US stocks taking a knock, as investors digest the latest developments from an upstart Chinese AI company called ...

The biggest risers on the FTSE 100 were British American Tobacco, up 142p to 3,150p, ConvaTec, up 9p to 248.4p, GSK, up 45.5p ...

Stocks across Asia lost ground on Monday as worries about Chinese AI company DeepSeek reverberated. The company's discounted R1 model knocked tech stocks, sending the Nikkei ( ^N225) in Japan 0.9% ...